Nothing Special   »   [go: up one dir, main page]

Urinary Tract Infection

Download as ppsx, pdf, or txt
Download as ppsx, pdf, or txt
You are on page 1of 23

Drugs for:

Urinary tract Infection

Dr. Ashish Bhattarai


lecturer
MD pharmacology
What is UTI?
• > 100000 organisms / ml in MID STREAM sample of urine

Clinical presentation:
• Asymptomatic bacteriuria
• Symptomatic acute urethritis and cystitis
• Acute prostatitis
• Acute pyelonephritis
• Septicemia (usually by Gm -ve)
Clinical feature
• Painful Micturition and dysuria,
• scalding pain in urethra during micturition;
• urine unpleasant odor and appear cloudy;
• gross hematuria
Whom?
• Men < 1 year and > 60 years

• Women : common 3% at age of 20


• Short urethra
• Absence of bactericidal prostatic
secretions

Residual urine after voiding increases


bacterial production
Injury to the mucosa
Presence of obstruction , foreign body
Diagnosis
• Clinical presentation
• Significant growth in MSU
• Pyuria (presence of neutrophils)
• X Ray, Ultrasonography
• Urethritis : infection of anterior urethral tract: dysuria , urgency ,
frequency of urination

• Cystitis : dysuria , frequency and urgency , pyuria and hematuria;


supra pubic pain: and often tenderness; After bladder has been
emptied there may be intense desire to pass more urine due to spasm
of inflamed bladder wall

• Acute pyelonephritis: infection of one or both kidney; some time


lower tract also; pyuria , fever, painful micturition

• Chronic pyelonephritis : particular type of pathology to the kidney


may or may not be associated with infection
Uncomplicated : UTI without underlying renal or neurological disease

Complicated: UTI with underlying structural, medical or neurological disease

Recurrent : > symptomatic UTIs within 12 months following clinical therapy


• Complicated
• Abnormal urinary tract ; obstruction, calculi, vesico uteric reflux, neurological
abnormality, chronic prostatitis, cystic kidney, analgesic nephropathy, renal
scarring

• Uncomplicated
• Normal renal function
• No associated disorders
• Anatomically and physiologically normal urinary tract
UTI

UPPER LOWER

Acute pyelonephritis
Cystitis
Chronic pyelonephritis
Prostatitis
Interstitial pyelonephritis
urethritis
Renal abscess/Peri-renal abscess
Cause
• E.coli 75% from fecal reservoir
• Other organisms: proteus, Pseudomonas , streptococci or staph.
Epidermidis

• In hospital: Klebsiella or streptococci

• S. saprophyticus : restricted to infections in young sexually active women


Virus: rubella mumps, HIV
Fungi: candida , Histoplasma
Protozoa: T. vaginalis, S. haematobium
Management
• Prophylactic measures in Prophylactic measures:
case of recurrent infection • Fluid intake
• Fluid intake at least 2lt/ day • Regular emptying of the
• Drug therapy bladder
• Complete emptying
• Double micturition if reflux
present
• Emptying bladder before
and after intercourse
Drugs groups effective for the treatment
• Quinolones
• Highly susceptible against E. Coli, Proteus, Salmonella typhi
• High cure rates, even in complicated cases

• Sulfonamides: attains bactericidal concentration in urine


• Cotrimoxazole: Courses of 3–10 days for lower and upper urinary tract
infections.
• Cotrimoxazole is specially valuable for chronic or recurrent cases or in prostatitis,
because trimethoprim is concentrated in prostate.
Drugs groups effective for the treatment
• Aminopenicillins
• Due to increased resistance fluroquinolones and Co-trimoxazole more
preferred for empirical therapy

• Cephalosporin:

• Amino glycosides: Gentamycin


• Note: UTI, urinary tract infection; TMP, trimethoprim; TMP-SMX, trimethoprim-sulfamethoxazole.
Urinary Antiseptics
• rapidly excreted in the urine and suppress the bacterial growth
• more effective in acidic urine because low pH is an independent inhibitor
of bacterial growth.

• Nitrofurantoin: result in DNA damage. It is active against most urinary


pathogens except pseudomonas and proteus. Resistance against it
develops slowly.
• Adverse effects include diarrhea, phototoxicity, neurotoxicity and
hemolysis in G-6-PD deficient patients.
• Methanamine Mandelate:
• It release formaldehyde at low pH , which is the major compound
having antibacterial activity.
• This drug is not effective against proteus because it releases NH3 and
alkalinizes the urine.

• Insoluble complex forms between formaldehyde and sulfonamides, so methanamine should not
be used with sulfonamides.
Nalidixic Acid
This is a quinolone drug and acts by inhibiting DNA gyrase.
This too is not effective against pseudomonas and proteus.
Resistance emerges rapidly and main adverse effect is neurotoxicity.

Phenazopyridine: It is not a urinary antiseptic but possesses analgesic


action and alleviates symptoms of dysuria, frequency, burning and
urgency.
Urinary pH in relation to use of AMAs
• Most drugs used in UTI attain high
concentration in urine and minor
changes in urinary pH do not
affect clinical outcome. In case of
inadequate response or in
complicated cases, measurement
of urinary pH may help
• In urease positive Proteus
infections ; impossible to acidify
urine; acidification should not be
attempted; drugs which act better
at higher pH should be used.
Bacteriuria in pregnancy
• To prevent from pyelonephritis
• 7 days course with:
• Cephalexin
• Nitrofurantoin
• Amoxicillin
• SAQ:
• List the drugs used in the management of Urinary tract infections
• Write short notes on Urinary antiseptics

MCQ (Important)
• Phenazopyridine: It is an orange dye with no urinary antiseptic but
analgesic property
• Nalidixic acid: quinolone drug and acts by inhibiting DNA gyrase
• Methanamine Mandelate: It release formaldehyde at low pH
• Nitrofurantoin can cause hemolysis in G-6-PD deficient patients.
Thank you

You might also like